Leuprorelin acetate Prescribing at WOODSTOCK BOWER GROUP PRACTICE
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
99
Total Quantity
99
NHS Cost
£9.4K
vs National Avg
+113.6%
WOODSTOCK BOWER GROUP PRACTICE prescribed 99 items of Leuprorelin acetate over the last 12 months at a cost of £9,392 to the NHS. This is 113.6% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
8
Jul 2026
7
Jul 2026
10
Jul 2026
9
Jul 2026
9
Jul 2026
9
Jul 2026
9
Jul 2026
10
Jul 2026
7
Jul 2026
8
Jul 2026
6
Jul 2026
7
Prescribing Details
| Total Items | 99 |
|---|---|
| Total Quantity | 99 |
| Total NHS Cost | £9,392 |
| Presentations | 4 different forms |
| vs National Average | +113.6% |
Leuprorelin acetate Prescribing Comparison
| This practice | 99 items |
|---|---|
| National average per practice | 46 items |
| Difference | +113.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.